Pacific Biosciences Of Stock Filter Stocks by Fundamentals
| PACB Stock | USD 1.26 0.01 0.79% |
Pacific Biosciences of fundamentals help investors to digest information that contributes to Pacific Biosciences' financial success or failures. It also enables traders to predict the movement of Pacific Stock. The fundamental analysis module provides a way to measure Pacific Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pacific Biosciences stock.
Pacific | Shares Owned by Institutions |
Pacific Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Pacific Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pacific Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pacific Biosciences' value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 5.7 M | Bank Of New York Mellon Corp | 2024-12-31 | 5.2 M | Jackson Square Partners, Llc | 2024-12-31 | 5.1 M | T. Rowe Price Investment Management,inc. | 2024-12-31 | 4.9 M | Goldman Sachs Group Inc | 2024-12-31 | 4.8 M | Northern Trust Corp | 2024-12-31 | 2.5 M | Soros Fund Management Llc | 2024-12-31 | 2.4 M | Bank Of America Corp | 2024-12-31 | 2.2 M | Charles Schwab Investment Management Inc | 2024-12-31 | 2.2 M | Ark Investment Management Llc | 2024-12-31 | 36 M | Blackrock Inc | 2024-12-31 | 24.6 M |
Pacific Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (2.01) % | ||||
| Operating Margin | (2.28) % | ||||
| Current Valuation | 672.69 M | ||||
| Shares Outstanding | 297.85 M | ||||
| Shares Owned By Insiders | 8.80 % | ||||
| Shares Owned By Institutions | 78.24 % | ||||
| Number Of Shares Shorted | 66.69 M | ||||
| Price To Earning | 197.88 X | ||||
| Price To Book | 0.77 X | ||||
| Price To Sales | 2.53 X | ||||
| Revenue | 154.01 M | ||||
| Gross Profit | 47.67 M | ||||
| EBITDA | (356.38 M) | ||||
| Net Income | (309.85 M) | ||||
| Cash And Equivalents | 834.34 M | ||||
| Cash Per Share | 3.69 X | ||||
| Total Debt | 672.43 M | ||||
| Debt To Equity | 1.51 % | ||||
| Current Ratio | 11.19 X | ||||
| Book Value Per Share | 1.72 X | ||||
| Cash Flow From Operations | (206.06 M) | ||||
| Short Ratio | 3.95 X | ||||
| Earnings Per Share | (1.59) X | ||||
| Price To Earnings To Growth | (0.17) X | ||||
| Target Price | 2.33 | ||||
| Number Of Employees | 575 | ||||
| Beta | 1.86 | ||||
| Market Capitalization | 390.19 M | ||||
| Total Asset | 1.26 B | ||||
| Retained Earnings | (2.15 B) | ||||
| Working Capital | 429.38 M | ||||
| Current Asset | 110.54 M | ||||
| Current Liabilities | 38.18 M | ||||
| Net Asset | 1.26 B |
About Pacific Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pacific Biosciences of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacific Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacific Biosciences of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Pacific Biosciences Piotroski F Score and Pacific Biosciences Altman Z Score analysis. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.59) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.